Document is current
Any future updates will be listed below
-
Authors
Zhou, Yan
Lagares, David https://orcid.org/0000-0002-7317-8796
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL147059-01)
- License Information
-
More Information
Article History
First Online: 11 February 2021
Competing interests
: D.L. declares that he has received research funding from Boehringer Ingelheim, Indalo Therapeutics, Merck and Unity Biotechnology. D.L. has a financial interest in Mediar Therapeutics and Zenon Biotech. The companies are developing treatments for organ fibrosis. D.L.’s interests were reviewed and are managed by MGH and Partners HealthCare in accordance with their conflict of interest policies.
